These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9576608)

  • 1. Multiple hypothalamic factors regulate pyroglutamyl peptidase II in cultures of adenohypophyseal cells: role of the cAMP pathway.
    Vargas MA; Bourdais J; Sanchez S; Uriostegui B; Moreno E; Joseph-Bravo P; Charli JL
    J Neuroendocrinol; 1998 Mar; 10(3):199-206. PubMed ID: 9576608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotropin-releasing hormone downregulates pyroglutamyl peptidase II activity in adenohypophyseal cells.
    Vargas MA; Joseph-Bravo P; Charli JL
    Neuroendocrinology; 1994 Sep; 60(3):323-30. PubMed ID: 7969791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyrotropin-releasing hormone-induced down-regulation of pyroglutamyl aminopeptidase II activity involves L-type calcium channels and cam kinase activities in cultures of adenohypophyseal cells.
    Vargas MA; Cisneros M; Joseph-Bravo P; Charli JL
    J Neuroendocrinol; 2002 Mar; 14(3):184-93. PubMed ID: 11999717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin-releasing hormone regulates the diurnal variation of pyroglutamyl aminopeptidase II activity in the male rat adenohypophysis.
    Angel Vargas M; Uribe RM; Cisneros M; Romero F; González S; Joseph-Bravo P; Charli JL
    Eur J Endocrinol; 2002 Sep; 147(3):363-9. PubMed ID: 12213674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of adenohypophyseal pyroglutamyl aminopeptidase II activity by thyrotropin-releasing hormone and phorbol esters.
    Vargas MA; Cisneros M; Joseph-Bravo P; Charli JL
    Endocrine; 2000 Dec; 13(3):267-72. PubMed ID: 11216637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid down regulation of pyroglutamyl peptidase II activity by arachidonic acid in primary cultures of adenohypophyseal cells.
    Baeza MA; Ponce G; Joseph-Bravo P; Charli JL
    Life Sci; 2001 Mar; 68(17):2051-60. PubMed ID: 11388706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting Enhances Pyroglutamyl Peptidase II Activity in Tanycytes of the Mediobasal Hypothalamus of Male Adult Rats.
    Lazcano I; Cabral A; Uribe RM; Jaimes-Hoy L; Perello M; Joseph-Bravo P; Sánchez-Jaramillo E; Charli JL
    Endocrinology; 2015 Jul; 156(7):2713-23. PubMed ID: 25942072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediobasal hypothalamic and adenohypophyseal TRH-degrading enzyme (PPII) is down-regulated by zinc deficiency.
    Alvarez-Salas E; Alcántara-Alonso V; Matamoros-Trejo G; Vargas MA; Morales-Mulia M; de Gortari P
    Int J Dev Neurosci; 2015 Nov; 46():115-24. PubMed ID: 26315400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anterior pituitary pyroglutamyl peptidase II activity controls TRH-induced prolactin release.
    Cruz R; Vargas MA; Uribe RM; Pascual I; Lazcano I; Yiotakis A; Matziari M; Joseph-Bravo P; Charli JL
    Peptides; 2008 Nov; 29(11):1953-64. PubMed ID: 18703099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tanycyte pyroglutamyl peptidase II contributes to regulation of the hypothalamic-pituitary-thyroid axis through glial-axonal associations in the median eminence.
    Sánchez E; Vargas MA; Singru PS; Pascual I; Romero F; Fekete C; Charli JL; Lechan RM
    Endocrinology; 2009 May; 150(5):2283-91. PubMed ID: 19179432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3-Me-His(2)]-TRH combined with dopamine withdrawal rapidly and transiently increases pyroglutamyl aminopeptidase II activity in primary cultures of adenohypophyseal cells.
    Bourdais J; Romero F; Uriostegui B; Cisneros M; Joseph-Bravo P; Charli JL
    Neuropeptides; 2000 Apr; 34(2):83-8. PubMed ID: 10985924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute administration of alcohol modulates pyroglutamyl amino peptidase II activity and mRNA levels in rat limbic regions.
    de Gortari P; Romero F; Cisneros M; Joseph-Bravo P
    Neurochem Int; 2005 Mar; 46(4):347-56. PubMed ID: 15707699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,3',5'-triiodo-L-thyronine reduces efficiency of mRNA knockdown by antisense oligodeoxynucleotides: a study with pyroglutamyl aminopeptidase II in adenohypophysis.
    Cruz R; Chávez-Gutiérrez L; Joseph-Bravo P; Charli JL
    Oligonucleotides; 2004; 14(3):176-90. PubMed ID: 15625913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in TRH and its degrading enzyme pyroglutamyl peptidase II, during the development of amygdaloid kindling.
    de Gortari P; Fernández-Guardiola A; Martinez A; Cisneros M; Joseph-Bravo P
    Brain Res; 1995 May; 679(1):144-50. PubMed ID: 7648256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyroglutamyl peptidase II inhibition enhances the analeptic effect of thyrotropin-releasing hormone in the rat medial septum.
    Lazcano I; Uribe RM; Martínez-Chávez E; Vargas MA; Matziari M; Joseph-Bravo P; Charli JL
    J Pharmacol Exp Ther; 2012 Jul; 342(1):222-31. PubMed ID: 22532627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRH inactivation in the extracellular compartment: role of pyroglutamyl peptidase II.
    Charli JL; Vargas MA; Cisneros M; de Gortari P; Baeza MA; Jasso P; Bourdais J; Peréz L; Uribe RM; Joseph-Bravo P
    Neurobiology (Bp); 1998; 6(1):45-57. PubMed ID: 9713831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some events of thyrotropin-releasing hormone metabolism are regulated in lactating and cycling rats.
    Uribe RM; Joseph-Bravo P; Pasten J; Ponce G; Méndez M; Covarrubias L; Charli JL
    Neuroendocrinology; 1991 Nov; 54(5):493-8. PubMed ID: 1684228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone rapidly regulates TRH mRNA levels in hypothalamic cell cultures: interaction with the cAMP pathway.
    Pérez-Martínez L; Carreón-Rodríguez A; González-Alzati ME; Morales C; Charli JL; Joseph-Bravo P
    Neuroendocrinology; 1998 Nov; 68(5):345-54. PubMed ID: 9822802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary adenylate cyclase-activating polypeptide regulates prolactin promoter activity via a protein kinase A-mediated pathway that is independent of the transcriptional pathway employed by thyrotropin-releasing hormone.
    Coleman DT; Chen X; Sassaroli M; Bancroft C
    Endocrinology; 1996 Apr; 137(4):1276-85. PubMed ID: 8625900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of TGF-beta1 on prolactin synthesis and secretion: an in-vitro study.
    Coya R; Alvarez CV; Perez F; Gianzo C; Diéguez C
    J Neuroendocrinol; 1999 May; 11(5):351-60. PubMed ID: 10320562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.